e-NA Biotec Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 1

Employees

  • Latest Deal Type
  • Crowdfunding

  • Latest Deal Amount
  • $253K

  • Investors
  • 1

e-NA Biotec General Information

Description

Developer of a drug discovery platform intended to create innovative nucleic acid drugs. The company is developing drugs focusing on the abnormal function of microRNAs whose expression is low in diseases, enabling healthcare professionals to perform non-clinical and clinical trials of the microRNA modality.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • TOIC Gifu Site, OKB Gifu University Plaza
  • 1-1 Yanagido
  • Gifu, Gifu 501-1112
  • Japan
+81
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • TOIC Gifu Site, OKB Gifu University Plaza
  • 1-1 Yanagido
  • Gifu, Gifu 501-1112
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

e-NA Biotec Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Equity Crowdfunding $253K Completed Startup
1. Seed Round 26-Mar-2020 Completed Startup
To view e-NA Biotec’s complete valuation and funding history, request access »

e-NA Biotec Patents

e-NA Biotec Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3041761-A1 Double-stranded nucleic acid molecule and use thereof Pending 31-Oct-2016
JP-6730717-B2 Micro rna-143 derivative Active 14-Apr-2016
EP-3444345-A1 Microrna-143 derivative Active 14-Apr-2016
EP-3444345-A4 Microrna-143 derivative Active 14-Apr-2016
EP-3444345-B1 Microrna-143 derivative Active 14-Apr-2016 C12N15/113
To view e-NA Biotec’s complete patent history, request access »

e-NA Biotec Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

e-NA Biotec Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bio Sight Capital Venture Capital Minority
To view e-NA Biotec’s complete investors history, request access »

e-NA Biotec FAQs

  • When was e-NA Biotec founded?

    e-NA Biotec was founded in 2018.

  • Where is e-NA Biotec headquartered?

    e-NA Biotec is headquartered in Gifu, Japan.

  • What is the size of e-NA Biotec?

    e-NA Biotec has 1 total employees.

  • What industry is e-NA Biotec in?

    e-NA Biotec’s primary industry is Drug Discovery.

  • Is e-NA Biotec a private or public company?

    e-NA Biotec is a Private company.

  • What is e-NA Biotec’s current revenue?

    The current revenue for e-NA Biotec is .

  • How much funding has e-NA Biotec raised over time?

    e-NA Biotec has raised $253K.

  • Who are e-NA Biotec’s investors?

    Bio Sight Capital has invested in e-NA Biotec.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process